Publications

Safety and immunogenicity of varied doses of R21/Matrix-M™ vaccine at three years follow-up: A phase 1b age de-escalation, dose-escalation trial in adults, children, and infants in Kilifi-Kenya

Sang S. et al, (2024)

ntibody responses to recombinant vesicular stomatitis virus-Zaire Ebolavirus vaccination for Ebola virus disease across doses and continents: 5-year durability.

Huttner A. et al, (2023), Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 29, 1587 - 1594

Kinetics of naturally induced binding and neutralising anti-SARS-CoV-2 antibody levels and potencies among SARS-CoV-2 infected Kenyans with diverse grades of COVID-19 severity: an observational study

Kimotho J. et al, (2023), Wellcome Open Research, 8, 350 - 350

Correlations between three ELISA protocols measurements of RTS,S/AS01-induced anti-CSP IgG antibodies

Mugo RM. et al, (2023), PLOS ONE, 18, e0286117 - e0286117

nti-merozoite antibodies induce natural killer cell effector function and are associated with immunity against malaria

Odera DO. et al, (2023), Science Translational Medicine, 15

Safety and immunogenicity of varied doses of R21/Matrix-M™ vaccine at three years follow-up: A phase 1b age de-escalation, dose-escalation trial in adults, children, and infants in Kilifi-Kenya.

Sang S. et al, (2023), Wellcome open research, 8

Controlled human malaria infection (CHMI) outcomes in Kenyan adults is associated with prior history of malaria exposure and anti-schizont antibody response

Kapulu MC. et al, (2022), BMC Infectious Diseases, 22

Phagocytosis of Plasmodium falciparum ring-stage parasites predicts protection against malaria

Musasia FK. et al, (2022), Nature Communications, 13

Breadth of Antibodies to Plasmodium falciparum Variant Surface Antigens Is Associated With Immunity in a Controlled Human Malaria Infection Study

Kimingi HW. et al, (2022), Frontiers in Immunology, 13

Vitamin D Deficiency and Its Association with Iron Deficiency in African Children

Mogire RM. et al, (2022), Nutrients, 14, 1372 - 1372

TRUE-1: Trial of Repurposed Unithiol for snakebite Envenoming phase 1 (safety, tolerability, pharmacokinetics and pharmacodynamics in healthy Kenyan adults)

Abouyannis M. et al, (2022), Wellcome Open Research, 7, 90 - 90

Individual-level variations in malaria susceptibility and acquisition of clinical protection

Valletta JJ. et al, (2022), Wellcome Open Research, 6, 22 - 22

10-year longitudinal study of malaria in children: Insights into acquisition and maintenance of naturally acquired immunity

Addy JWG. et al, (2022), Wellcome Open Research, 6, 79 - 79

Transcriptomic signatures induced by the Ebola virus vaccine rVSVΔG-ZEBOV-GP in adult cohorts in Europe, Africa, and North America: a molecular biomarker study

Vianello E. et al, (2022), The Lancet Microbe, 3, e113 - e123

Individual-level variations in malaria susceptibility and acquisition of clinical protection

Valletta JJ. et al, (2022)

Cookies on this website

Search results (79)